PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PaxVax Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10882
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PaxVax Inc (PaxVax) is a vaccine company that develops and commercializes specialty vaccines against infectious diseases. The company develops scalable, and oral vaccines. Its activities include early-stage preclinical research and development, clinical study support, drug product manufacturing, drug substance sterile fill and finish, and packaging infrastructure. PaxVax commercializes vaccines for cholera, HIV, zika, endemic infectious diseases, chikungunya, hepatitis A, adenovirus and dengue. The company’s vector vaccines are based on adenovirus serotypes 4 and 7 and the A549 cell substrate. It operates through its laboratory and manufacturing facilities located in San Diego, California; and Thorishaus, Switzerland. PaxVax is headquartered in Redwood City, California, the US.

PaxVax Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PaxVax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PaxVax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PaxVax Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
PaxVax Acquires Vivotif from Crucell 10
Venture Financing 11
PaxVax Raises USD12 Million in Extended Series B Financing 11
PaxVax Raises USD50 Million in Venture Debt Financing 12
PaxVax Raises US$6 Million In Venture Financing 13
PaxVax Raises US$22 Million In Series B Financing 14
Private Equity 15
Cerberus Capital Invests USD105 Million in PaxVax 15
Partnerships 16
PaxVax and TerahVax Korea Enter into Distribution Agreement 16
PaxVax Enters into Distribution Agreement with Seqirus 17
Valneva Enters into Distribution Agreement with PaxVax 18
PaxVax Enters into Distribution Agreement with Novartis 19
PaxVax Enters into Distribution Agreement with BioCSL 20
PaxVax Enters into Distribution Agreement with Valneva 21
Licensing Agreements 22
PaxVax Enters into Licensing Agreement with National Institutes of Health 22
PaxVax Enters into Licensing Agreement with Leukocare 23
PaxVax Enters into Licensing Agreement with University Of California, San Diego 24
Acquisition 25
Emergent BioSolutions Acquires PaxVax from Cerberus Capital Management for USD270 Million 25
PaxVax Inc – Key Competitors 27
PaxVax Inc – Key Employees 28
PaxVax Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Government and Public Interest 30
Jun 29, 2018: Same Vaccine Concept for Ebola Appears Effective Against Nipah Virus 30
Clinical Trials 31
May 04, 2018: FDA Grants PaxVax Fast Track Designation for its Chikungunya Vaccine 31
Apr 25, 2018: PaxVax Announces the Initiation of Phase 2b Trial for its Chikungunya Vaccine 32
May 08, 2017: PaxVax Initiates Clinical Trials of a Modernized Adenovirus Vaccine in Collaboration with the U.S. Army Medical Materiel Development Activity and the Walter Reed Army Institute of Research to Protect U.S. Military Personnel 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
PaxVax Inc, Pharmaceuticals & Healthcare, Key Facts 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PaxVax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PaxVax Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PaxVax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PaxVax Acquires Vivotif from Crucell 10
PaxVax Raises USD12 Million in Extended Series B Financing 11
PaxVax Raises USD50 Million in Venture Debt Financing 12
PaxVax Raises US$6 Million In Venture Financing 13
PaxVax Raises US$22 Million In Series B Financing 14
Cerberus Capital Invests USD105 Million in PaxVax 15
PaxVax and TerahVax Korea Enter into Distribution Agreement 16
PaxVax Enters into Distribution Agreement with Seqirus 17
Valneva Enters into Distribution Agreement with PaxVax 18
PaxVax Enters into Distribution Agreement with Novartis 19
PaxVax Enters into Distribution Agreement with BioCSL 20
PaxVax Enters into Distribution Agreement with Valneva 21
PaxVax Enters into Licensing Agreement with National Institutes of Health 22
PaxVax Enters into Licensing Agreement with Leukocare 23
PaxVax Enters into Licensing Agreement with University Of California, San Diego 24
Emergent BioSolutions Acquires PaxVax from Cerberus Capital Management for USD270 Million 25
PaxVax Inc, Key Competitors 27
PaxVax Inc, Key Employees 28
PaxVax Inc, Other Locations 29

List of Figures
PaxVax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PaxVax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kumba Iron Ore Ltd:企業の戦略・SWOT・財務情報
    Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report Summary Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Teledyne Technologies Incorporated (TDY):石油・ガス:M&Aディール及び事業提携情報
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of enabling technologies for industrial growth markets. The company’s product portfolio comprises digital imaging sensors, cameras and systems, infrared and X-ray spectra, monitoring and control instrumentation. It also offers elect …
  • Strategic Resources Inc (STI):企業の戦略的SWOT分析
    Strategic Resources Inc (STI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • QuantuMDx Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary QuantuMDx Group Ltd (QuantuMDx) is a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious dise …
  • Novavax, Inc.:企業のM&A・事業提携・投資動向
    Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novavax, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Intra Energy Corporation Ltd (IEC):電力:M&Aディール及び事業提携情報
    Summary Intra Energy Corporation Limited (IEC), formerly Atomic Resources Limited, is a mining and energy company that operates through subsidiaries, affiliates, and joint ventures. It explores and mines coal, mineral resources, ore reserves, and uranium through operating interests in various mines. …
  • China Synthetic Rubber Corp (2104):企業の財務・戦略的SWOT分析
    China Synthetic Rubber Corp (2104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PPL Corporation (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary PPL Corp (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and solar s …
  • St. Jude Children’s Research Hospital Inc-製薬・医療分野:企業M&A・提携分析
    Summary St. Jude Children’s Research Hospital Inc (St. Jude) is a healthcare service provider that offers research and clinical care services for children with catastrophic diseases. The hospital provides treatment programs such as brain tumors, leukemia, infectious diseases, immunodeficiency diseas …
  • Aeterna Zentaris Inc (AEZS):医療機器:M&Aディール及び事業提携情報
    Summary Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company that focuses on the development and commercialization of novel pharmaceutical therapies for the treatment of endocrine disorders. The company’s lead product, macimorelin, a ghrelin receptor agonist and orally-ac …
  • Zenotech Laboratories Ltd (532039):企業の財務・戦略的SWOT分析
    Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Wearable Health Solutions Inc (WHSI):医療機器:M&Aディール及び事業提携情報
    Summary Wearable Health Solutions Inc (Wearable Health Solutions), formerly Medical Alarm Concepts Holdings Inc, is a medical equipment manufacturing company that offers mobile health (mHealth) products and services. The company’s products include wearable healthcare products, medical alarm devices, …
  • AECOM (ACM):企業の財務・戦略的SWOT分析
    AECOM (ACM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the poten …
  • Amicus Therapeutics Inc (FOLD):企業の財務・戦略的SWOT分析
    Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • 7C Solarparken AG (HRPK):企業の財務・戦略的SWOT分析
    Summary 7C Solarparken AG (7C Solarparken), formerly Colexon Energy AG is a renewable energy company that develops and operates photovoltaic farms. The company operates, maintains, and administrates the photovoltaic power plants with acquisition, financing and optimization of operating assets. Its d …
  • EnerVest Ltd:企業のM&A・事業提携・投資動向
    EnerVest Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnerVest Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • NCC Ltd (NCC):企業の財務・戦略的SWOT分析
    NCC Ltd (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Narada Power Source Co Ltd (300068):企業の財務・戦略的SWOT分析
    Summary Narada Power Source Co Ltd (Narada Power) is a battery manufacturer and distributor that markets and supplies stored energy solutions. The company's products include eos series batteries, acme series, acmeG series, GP series, TTG series, TT series, eosG series, GPG series, MP series, HRL ser …
  • genOway SA (ALGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary genOway SA (genOway) is a biotechnology company that develops genetically modified mouse, rat and cellular models for pharmaceutical companies and research institutes. The company develops several technology platforms such as safe DNA transgenesis, quick knock-in, safe in vivo RNAi and safe …
  • Continuus Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Continuus Pharmaceuticals Inc (Continuus) is a provider of integrated continuous manufacturing technology for small molecule pharmaceuticals. The company offers an integrated continuous manufacturing technology that produces finished drug tablets from raw chemical ingredients without interru …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆